Chart: Pending FDA Guidance Documents For Devices
This article was originally published in The Gray Sheet
You may also be interested in...
Schultz: CDRH Too Slow In Getting Out Guidance Docs And Unlikely To Improve
The pace at which FDA's device center puts out guidance documents is not adequate, admits CDRH Director Dan Schultz, but it is unlikely to improve anytime soon, he said
Lab Stakeholders Still Oppose FDA’s Multivariate Assay Policy
Laboratories are urging FDA to once again rework, if not abandon, its proposal to actively regulate certain lab-developed tests, while diagnostics companies are split on the issue
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.